Track topics on Twitter Track topics that are important to you
Silence Therapeutics' (LON:SLN) new CEO Annalisa Jenkins sat down with Proactive's Andrew Scott to discuss her strategy for taking the drug developer forward and the 'exciting opportunities' in the ...
LONDON, November 20, 2018 /PRNewswire/ -- J P Jenkins (jpjenkins.com) would like to welcome Sama Resources Inc. (TSX.V: SME, hereinafter "Sama"), one of the most Read more...
WASHINGTON, Dec. 1, 2018 /PRNewswire/ -- Today AARP CEO Jo Ann Jenkins released a statement in reaction to the news of former President George H.W. Read more...
Silence Therapeutics' (LON:SLN) executive chair Annalisa Jenkins sat down with Proactive's Andrew Scott to discuss her strategy for taking the drug developer forward and the 'exciting opportunities'...
“This will surprise many people as it contradicts our intuitive understanding,” said Rob Jenkins, a psychologist at the University of York.
Dr. Gareth Jenkins will focus on identifying technology that will enable Arcinova to enhance pharmaceutical development
Ian Jenkins, CEO of Frelii, says through use of DNA testing and the power of artificial intelligence (AI) it is possible to customize the best diet and health plan available for each individual. LEHI,...
Somnote (Chloral Hydrate Capsules, USP 500 mg) CIV
This study aims to assess the validity and reliability of the Jenkins Sleep Evaluation Scale (JSS) when applied to a Turkish population with rheumatoid arthritis.
Local Retropharyngeal Administration of Corticosteroids: What's the Trade-Off?: Commentary on an article by Tyler James Jenkins, MD, et al.: "The Effect of Local Versus Intravenous Corticosteroids on the Likelihood of Dysphagia and Dysphonia Following Anterior Cervical Discectomy and Fusion. A Single-Blinded, Prospective, Randomized Controlled Trial".
The steady-state visual evoked potential (SSVEP) based brain-computer interface (BCI) has received increasing attention in recent years. The present study proposes a new method for recognition based o...
This article presents an account of how Japanese parents in a family support group for mental illness constructed understandings of care for adult children with serious mental illness, primarily schiz...
Microfluidic culture has the potential to revolutionize cancer diagnosis and therapy. Indeed, several microdevices are being developed specifically for clinical use to test novel cancer therapeutics. ...
Consumption of a low glycemic index (GI) diet has been shown to improve glycaemic control in type 2 diabetics(Brand−Miller et al., 2003; Jenkins et al., 2008). In addition to the benefit...
Growth hormone (GH) is important for growth in childhood, but also has important effects on a number of tissues throughout life. GH deficiency and GH excess (acromegaly, caused by a pituit...
We are a leading firm of patent and trademark agents with offices in London, Munich and Alicante. We are qualified to represent clients before the UK Patent Office, the European Patent Office, the Ger...
OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The companyâs first offering, OncoWellCE,...
We have published hundreds of Tyrie Jenkins, M.D. news stories on BioPortfolio along with dozens of Tyrie Jenkins, M.D. Clinical Trials and PubMed Articles about Tyrie Jenkins, M.D. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tyrie Jenkins, M.D. Companies in our database. You can also find out about relevant Tyrie Jenkins, M.D. Drugs and Medications on this site too.